MTOR and gastric cancer: Western blot OE CM-treated gastric cancer cells expressed low levels of p-mTOR, p-AKT, and p-70S6K, which illustrated that OE CM may inhibit the AKT/mTOR signalling pathway and attenuate M2-mediated malignant phenotypes.